INFLUENCE OF LIVER-DAMAGE ON ANTIPYRINE METABOLITE FORMATION IN RATS

被引:6
作者
TANAKA, E
ETOH, H
ISHIKAWA, A
NAKANO, M
MISAWA, S
机构
[1] UNIV TSUKUBA,INST CLIN MED,SAKURA,IBARAKI 305,JAPAN
[2] CHIBA UNIV,PATHOGEN FUNGI & MICROBIOL TOXICOSES RES CTR,CHIBA 280,JAPAN
关键词
D O I
10.3109/00498259109039506
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The effects of three types of liver damage induced by carbon tetrachloride (CCl4), D-galactosamine (Ga1N) and alpha-naphthylisothiocyanate (ANIT) on antipyrine (AP) metabolism was studied in rats. 2. The serum half-life (t1/2) of AP (50 mg/kg, i.p.) was increased and total body clearance (CL) decreased in all three types of liver damage; the apparent volume of distribution (V(d)) was relatively unchanged. 3. Rates of formation of AP metabolites (CL(m)) were lower than those in the control group in all three types of liver damage. 4. Rates of urinary excretion (% dose) of AP metabolites, 3-hydroxymethylantipyrine (HMA) and 3-hydroxymethyl-3-norantipyrine (NORA) were decreased in all three types of liver damage. However, the rate for 4-hydroxyantipyrine (OHA) was lower only in the Ga1N-treated rats. 5. The percentage conjugation of HMA was higher in the ANIT-treated rats than in the control group, and percentage conjugation of NOR was lower only in the Ga1N-treated rats. 6. These results indicate that the pathways of oxidation and conjugation of AP metabolism are not affected to the same extents by different types of liver damage.
引用
收藏
页码:663 / 667
页数:5
相关论文
共 10 条
[1]   UDP-GLUCURONOSYLTRANSFERASES [J].
BURCHELL, B ;
COUGHTRIE, MWH .
PHARMACOLOGY & THERAPEUTICS, 1989, 43 (02) :261-289
[2]   STUDIES OF THE DIFFERENT METABOLIC PATHWAYS OF ANTIPYRINE IN MAN - ORAL VERSUS IV ADMINISTRATION AND THE INFLUENCE OF URINARY COLLECTION TIME [J].
DANHOF, M ;
VANZUILEN, A ;
BOEIJINGA, JK ;
BREIMER, DD .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 21 (05) :433-441
[3]   STUDIES ON THE DIFFERENT METABOLIC PATHWAYS OF ANTIPYRINE IN RATS - INFLUENCE OF PHENOBARBITAL AND 3-METHYLCHOLANTHRENE TREATMENT [J].
DANHOF, M ;
KROM, DP ;
BREIMER, DD .
XENOBIOTICA, 1979, 9 (11) :695-702
[4]   TRIMETHADIONE AS A MODEL-DRUG FOR THE EVALUATION OF HEPATIC DRUG-METABOLIZING CAPACITY IN NORMAL AND D-GALACTOSAMINE INTOXICATED RATS [J].
TANAKA, E ;
KINOSHITA, H ;
YOSHIDA, T ;
KUROIWA, Y .
JAPANESE JOURNAL OF PHARMACOLOGY, 1982, 32 (06) :1182-1185
[5]   DETERMINATION OF PLASMA TRIMETHADIONE AND ITS METABOLITE IN CARBON TETRACHLORIDE-INTOXICATED RAT-LIVER - A USEFUL TOOL FOR ESTIMATION OF HEPATIC DRUG-METABOLIZING CAPACITY [J].
TANAKA, E ;
KINOSHITA, H ;
YOSHIDA, T ;
KUROIWA, Y .
JOURNAL OF PHARMACOBIO-DYNAMICS, 1981, 4 (12) :961-967
[6]   TRIMETHADIONE AS A MODEL-DRUG FOR THE EVALUATION OF HEPATIC DRUG-METABOLIZING CAPACITY IN NORMAL AND ALPHA-NAPHTHYLISOTHIOCYANATE-INTOXICATED RATS [J].
TANAKA, E ;
KINOSHITA, H ;
YOSHIDA, T ;
KUROIWA, Y .
PHARMACOLOGY, 1982, 25 (04) :202-209
[7]   AUTOMATED HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF ANTIPYRINE AND ITS MAIN METABOLITES IN PLASMA, SALIVA AND URINE, INCLUDING 4,4'-DIHYDROXY-ANTIPYRINE [J].
TEUNISSEN, MWE ;
MEERBURGVANDERTORREN, JE ;
VERMEULEN, NPE ;
BREIMER, DD .
JOURNAL OF CHROMATOGRAPHY, 1983, 278 (02) :367-378
[8]  
TEUNISSEN MWE, 1984, THESIS
[9]  
VESELL ES, 1979, CLIN PHARMACOL THER, V26, P275
[10]   INDUCTION STUDIES ON THE FUNCTIONAL-HETEROGENEITY OF RAT-LIVER UDP-GLUCURONOSYLTRANSFERASES [J].
WATKINS, JB ;
GREGUS, Z ;
THOMPSON, TN ;
KLAASSEN, CD .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1982, 64 (03) :439-446